Percent free prostate-specific antigen after radiotherapy for prostate cancer - 8 to 10 ng/mL total PSA

By Crook J.M.   Bunting P.S.  

Urology, Vol. 52, Iss. 1, 1998-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

By Becker C.   Piironen T.   Pettersson K.   Hugosson J.   Lilja H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 694-699

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

By Krumholtz J.S.   Carvalhal G.F.   Ramos C.G.   Smith D.S.   Thorson P.   Yan Y.   Humphrey P.A.   Roehl K.A.   Catalona W.J.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 469-473

Elsevier

Access to resources Recommend Favorite

The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4–10 ng/mL

By Ng C.   Chiu Peter   Lam N.   Lam H.   Lee Kim   Hou Simon  

International Urology and Nephrology, Vol. 46, Iss. 4, 2014-04 ,pp. : 711-717

Springer Publishing Company

Access to resources Recommend Favorite

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL

By Eastham J.A.   May R.   Robertson J.L.   Sartor O.   Kattan M.W.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 709-713

Elsevier

Access to resources Recommend Favorite